Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Sep;93(3):382–386. doi: 10.1111/j.1365-2249.1993.tb08189.x

Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvants

R Perraut, A R Lussow, S Gavoille, O Garraud, H Matile, C Tougne, J Van Embden, R Van Der Zee, P-H Lambert, J Gysin, G Del Giudice
PMCID: PMC1554911  PMID: 8370164

Abstract

We have previously shown in mice that antibodies can be induced to synthetic malaria peptides conjugated to mycobacterial antigens, such as purified protein derivative (PPD) or heat shock proteins (hsp), and given in the absence of adjuvants after a previous priming with bacille Calmette—Guérin (BCG). In the present study we investigated this model of immunization in the non-human primates, Saimiri sciureus monkeys. Monkeys primed with BCG subcutaneously and then immunized subcutaneously with the Plasmodium falciparum sporozoite (NANP)40 synthetic peptide conjugated to PPD or mycobacterial hsp of 65 or 70 kD, in the absence of adjuvants, produced anti-peptide and anti-sporozoite IgG antibodies. Interestingly, the carrier effect of the hsp of 70 kD for the induction of anti-(NANP)40 antibodies was also observed in the absence of a previous priming with BCG. These data suggest that such a vaccination strategy may be applied to humans.

Full text

PDF
382

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrios C., Lussow A. R., Van Embden J., Van der Zee R., Rappuoli R., Costantino P., Louis J. A., Lambert P. H., Del Giudice G. Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming. Eur J Immunol. 1992 Jun;22(6):1365–1372. doi: 10.1002/eji.1830220606. [DOI] [PubMed] [Google Scholar]
  2. Cohen I. R. Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annu Rev Immunol. 1991;9:567–589. doi: 10.1146/annurev.iy.09.040191.003031. [DOI] [PubMed] [Google Scholar]
  3. Del Giudice G., Cooper J. A., Merino J., Verdini A. S., Pessi A., Togna A. R., Engers H. D., Corradin G., Lambert P. H. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines. J Immunol. 1986 Nov 1;137(9):2952–2955. [PubMed] [Google Scholar]
  4. Del Giudice G., Gervaix A., Costantino P., Wyler C. A., Tougne C., de Graeff-Meeder E. R., van Embden J., van der Zee R., Nencioni L., Rappuoli R. Priming to heat shock proteins in infants vaccinated against pertussis. J Immunol. 1993 Mar 1;150(5):2025–2032. [PubMed] [Google Scholar]
  5. Del Giudice G., Lussow A. R., Lambert P. H. Heat shock proteins as "super"-carriers for sporozoite peptide vaccines? Res Immunol. 1991 Oct;142(8):703–707. doi: 10.1016/0923-2494(91)90153-a. [DOI] [PubMed] [Google Scholar]
  6. Del Giudice G. New carriers and adjuvants in the development of vaccines. Curr Opin Immunol. 1992 Aug;4(4):454–459. doi: 10.1016/s0952-7915(06)80038-5. [DOI] [PubMed] [Google Scholar]
  7. Del Giudice G., Verdini A. S., Pinori M., Pessi A., Verhave J. P., Tougne C., Ivanoff B., Lambert P. H., Engers H. D. Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides. J Clin Microbiol. 1987 Jan;25(1):91–96. doi: 10.1128/jcm.25.1.91-96.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Esposito G., Pessi A., Verdini A. S. 1H-NMR studies of synthetic polypeptide models of Plasmodium falciparum circumsporozoite protein tandemly repeated sequence. Biopolymers. 1989 Jan;28(1):225–246. doi: 10.1002/bip.360280124. [DOI] [PubMed] [Google Scholar]
  9. Garsia R. J., Hellqvist L., Booth R. J., Radford A. J., Britton W. J., Astbury L., Trent R. J., Basten A. Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun. 1989 Jan;57(1):204–212. doi: 10.1128/iai.57.1.204-212.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Good M. F., Berzofsky J. A., Maloy W. L., Hayashi Y., Fujii N., Hockmeyer W. T., Miller L. H. Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. J Exp Med. 1986 Aug 1;164(2):655–660. doi: 10.1084/jem.164.2.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gysin J., Pauillac S., Fandeur T. Characterization by anti-Ig monoclonal antibodies of protective and non-protective antibodies against asexual forms of Plasmodium falciparum in the Saimiri monkey. Ann Inst Pasteur Immunol. 1987 Nov-Dec;138(6):829–844. doi: 10.1016/s0769-2625(87)80003-x. [DOI] [PubMed] [Google Scholar]
  12. Jindal S., Dudani A. K., Singh B., Harley C. B., Gupta R. S. Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonins and to the 65-kilodalton mycobacterial antigen. Mol Cell Biol. 1989 May;9(5):2279–2283. doi: 10.1128/mcb.9.5.2279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lussow A. R., Aguado M. T., Del Giudice G., Lambert P. H. Towards vaccine optimisation. Immunol Lett. 1990 Aug;25(1-3):255–263. doi: 10.1016/0165-2478(90)90124-9. [DOI] [PubMed] [Google Scholar]
  14. Lussow A. R., Barrios C., van Embden J., Van der Zee R., Verdini A. S., Pessi A., Louis J. A., Lambert P. H., Del Giudice G. Mycobacterial heat-shock proteins as carrier molecules. Eur J Immunol. 1991 Oct;21(10):2297–2302. doi: 10.1002/eji.1830211002. [DOI] [PubMed] [Google Scholar]
  15. Lussow A. R., Del Giudice G., Rénia L., Mazier D., Verhave J. P., Verdini A. S., Pessi A., Louis J. A., Lambert P. H. Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants. Proc Natl Acad Sci U S A. 1990 Apr;87(8):2960–2964. doi: 10.1073/pnas.87.8.2960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mehlert A., Young D. B. Biochemical and antigenic characterization of the Mycobacterium tuberculosis 71kD antigen, a member of the 70kD heat-shock protein family. Mol Microbiol. 1989 Feb;3(2):125–130. doi: 10.1111/j.1365-2958.1989.tb01801.x. [DOI] [PubMed] [Google Scholar]
  17. Milich D. R. Synthetic T and B cell recognition sites: implications for vaccine development. Adv Immunol. 1989;45:195–282. doi: 10.1016/s0065-2776(08)60694-x. [DOI] [PubMed] [Google Scholar]
  18. Nardin E., Gwadz R. W., Nussenzweig R. S. Characterization of sporozoite surface antigens by indirect immunofluorescence: detection of stage- and species-specific antimalarial antibodies. Bull World Health Organ. 1979;57 (Suppl 1):211–217. [PMC free article] [PubMed] [Google Scholar]
  19. Nussenzweig V., Nussenzweig R. S. Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol. 1989;45:283–334. doi: 10.1016/s0065-2776(08)60695-1. [DOI] [PubMed] [Google Scholar]
  20. Thole J. E., Dauwerse H. G., Das P. K., Groothuis D. G., Schouls L. M., van Embden J. D. Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun. 1985 Dec;50(3):800–806. doi: 10.1128/iai.50.3.800-806.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Thole J. E., van Schooten W. C., Keulen W. J., Hermans P. W., Janson A. A., de Vries R. R., Kolk A. H., van Embden J. D. Use of recombinant antigens expressed in Escherichia coli K-12 to map B-cell and T-cell epitopes on the immunodominant 65-kilodalton protein of Mycobacterium bovis BCG. Infect Immun. 1988 Jun;56(6):1633–1640. doi: 10.1128/iai.56.6.1633-1640.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Togna A. R., Del Giudice G., Verdini A. S., Bonelli F., Pessi A., Engers H. D., Corradin G. Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice. J Immunol. 1986 Nov 1;137(9):2956–2960. [PubMed] [Google Scholar]
  23. van Eden W., Thole J. E., van der Zee R., Noordzij A., van Embden J. D., Hensen E. J., Cohen I. R. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature. 1988 Jan 14;331(6152):171–173. doi: 10.1038/331171a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES